121 related articles for article (PubMed ID: 9291400)
21. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Cascavilla N
Leuk Lymphoma; 2007 Jun; 48(6):1072-80. PubMed ID: 17577769
[TBL] [Abstract][Full Text] [Related]
22. Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
Anaissie EJ; Kontoyiannis DP; O'Brien S; Kantarjian H; Robertson L; Lerner S; Keating MJ
Ann Intern Med; 1998 Oct; 129(7):559-66. PubMed ID: 9758577
[TBL] [Abstract][Full Text] [Related]
23. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
24. Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.
Lanasa MC; Andritsos L; Brown JR; Gabrilove J; Caligaris-Cappio F; Ghia P; Larson RA; Kipps TJ; Leblond V; Milligan DW; Janssens A; Johnson AJ; Heerema NA; Bühler A; Stilgenbauer S; Devin J; Hallek M; Byrd JC; Grever MR
Leuk Res; 2015 May; 39(5):495-500. PubMed ID: 25804339
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
[TBL] [Abstract][Full Text] [Related]
28. [Successful treatment for advanced and refractory chronic lymphocytic leukemia with fludarabine phosphate].
Takeuchi M; Tada A; Soda R; Takahashi K
Rinsho Ketsueki; 1997 Sep; 38(9):792-4. PubMed ID: 9364873
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
32. Current approaches to the treatment and management of chronic lymphocytic leukaemia.
Montserrat E; Rozman C
Drugs; 1994; 47 Suppl 6():1-9. PubMed ID: 7525184
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Faderl S; Rai K; Gribben J; Byrd JC; Flinn IW; O'Brien S; Sheng S; Esseltine DL; Keating MJ
Cancer; 2006 Sep; 107(5):916-24. PubMed ID: 16832816
[TBL] [Abstract][Full Text] [Related]
34. p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
Valgañón M; Giraldo P; Agirre X; Larráyoz MJ; Rubio-Martinez A; Rubio-Felix D; Calasanz MJ; Odero MD
Br J Haematol; 2005 Apr; 129(1):53-9. PubMed ID: 15801955
[TBL] [Abstract][Full Text] [Related]
35. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
[TBL] [Abstract][Full Text] [Related]
36. [Anemia in chronic lymphatic leukemia: is erythropoietin the solution?].
de Gaona ER; Rifón J; Pérez-Calvo J; Bendandi M; Iglesias R; Panizo C
Rev Med Univ Navarra; 2007; 51(1):3-10. PubMed ID: 17555114
[TBL] [Abstract][Full Text] [Related]
37. [Long-term results with fludarabine monotherapy in chronic lymphocytic leukemia].
Varga F; Lehoczky D; Demeter J
Orv Hetil; 1999 Aug; 140(31):1731-5. PubMed ID: 10463032
[TBL] [Abstract][Full Text] [Related]
38. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
39. Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
Molica S; Montillo M; Ribatti D; Mirabelli R; Tedeschi A; Ricci F; Veronese S; Vacca A; Morra E
Haematologica; 2007 Oct; 92(10):1367-74. PubMed ID: 17768114
[TBL] [Abstract][Full Text] [Related]
40. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
